About Us

Publications

BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: Some Publications were unable to be listed below - please see that listing here. All other publications based on PubMedIDs are listed below.

 

Found 139 results
2014
J. L. M. Ferrara, Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007., Biol Blood Marrow Transplant, vol. 20, no. 2, pp. 149-53, 2014.
J. A. Roth, Bensink, M. E., O'Donnell, P. V., Fuchs, E. J., Eapen, M., and Ramsey, S. D., Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer., J Comp Eff Res, vol. 3, no. 2, pp. 135-44, 2014.
P. B. Jacobsen, Le-Rademacher, J., Jim, H., Syrjala, K., Wingard, J. R., Logan, B., Wu, J., Majhail, N. S., Wood, W., J Rizzo, D., Geller, N. L., Kitko, C., Faber, E., Abidi, M. H., Slater, S., Horowitz, M. M., and Lee, S. J., Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902., Biol Blood Marrow Transplant, vol. 20, no. 10, pp. 1530-6, 2014.
G. E. Switzer, Bruce, J. G., Harrington, D., Haagenson, M., Drexler, R., Foley, A., Confer, D., Bishop, M., Anderlini, P., Rowley, S., Leitman, S. F., Anasetti, C., and Wingard, J. R., Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201., Biol Blood Marrow Transplant, vol. 20, no. 1, pp. 118-27, 2014.
E. K. Waller, Logan, B. R., Harris, W. A. C., Devine, S. M., Porter, D. L., Mineishi, S., McCarty, J. M., Gonzalez, C. E., Spitzer, T. R., Krijanovski, O. I., Linenberger, M. L., Woolfrey, A., Howard, A., Wu, J., Confer, D. L., and Anasetti, C., Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201., J Clin Oncol, vol. 32, no. 22, pp. 2365-72, 2014.
M. Eapen, O'Donnell, P., Brunstein, C. G., Wu, J., Barowski, K., Mendizabal, A., and Fuchs, E. J., Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies., Biol Blood Marrow Transplant, vol. 20, no. 10, pp. 1485-92, 2014.
W. Saber, Le Rademacher, J., Sekeres, M., Logan, B., Lewis, M., Mendizabal, A., Leifer, E., Appelbaum, F. R., Horowitz, M. M., Nakamura, R., and Cutler, C. S., Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and M, Biol Blood Marrow Transplant, vol. 20, no. 10, pp. 1566-72, 2014.
J. E. Wagner, Eapen, M., Carter, S., Wang, Y., Schultz, K. R., Wall, D. A., Bunin, N., Delaney, C., Haut, P., Margolis, D., Peres, E., Verneris, M. R., Walters, M., Horowitz, M. M., and Kurtzberg, J., One-unit versus two-unit cord-blood transplantation for hematologic cancers., N Engl J Med, vol. 371, no. 18, pp. 1685-94, 2014.
J. Bolaños-Meade, Logan, B. R., Alousi, A. M., Antin, J. H., Barowski, K., Carter, S. L., Goldstein, S. C., Hexner, E. O., Horowitz, M. M., Lee, S. J., Levine, J. E., MacMillan, M. L., Martin, P. J., Mendizabal, A. M., Nakamura, R., Pasquini, M. C., Weisdorf, D. J., Westervelt, P., and Ho, V. T., Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802., Blood, vol. 124, no. 22, pp. 3221-7; quiz 3335, 2014.
G. A. Yanik, Horowitz, M. M., Weisdorf, D. J., Logan, B. R., Ho, V. T., Soiffer, R. J., Carter, S. L., Wu, J., Wingard, J. R., DiFronzo, N. L., Ferrara, J. L., Giralt, S., Madtes, D. K., Drexler, R., White, E. S., and Cooke, K. R., Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials ne, Biol Blood Marrow Transplant, vol. 20, no. 6, pp. 858-64, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. - H., Carter, S. L., Horowitz, M. M., and Antin, J. H., Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT., Blood, vol. 124, no. 8, pp. 1372-7, 2014.
E. Atallah, Bylow, K., Troy, J., and Saber, W., Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT)., Curr Hematol Malig Rep, vol. 9, no. 1, pp. 57-65, 2014.
2012
J. Levine, Logan, B., Wu, J., Alousi, A. M., Bolaños-Meade, J., Ferrara, J. L. M., Ho, V. T., Weisdorf, D. J., and Paczesny, S., Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: A Blood and Marrow Transplant Clinical Trials Network study., 2012.
C. A. Keever-Taylor, Devine, S. M., Soiffer, R. J., Mendizabal, A., Carter, S., Pasquini, M. C., Hari, P. N., Stein, A., Lazarus, H. M., Linker, C., Goldstein, S. C., Stadtmauer, E. A., and O'Reilly, R. J., Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303., Biol Blood Marrow Transplant, vol. 18, no. 5, pp. 690-7, 2012.
M. C. Pasquini, Devine, S., Mendizabal, A., Baden, L. R., Wingard, J. R., Lazarus, H. M., Appelbaum, F. R., Keever-Taylor, C. A., Horowitz, M. M., Carter, S., O'Reilly, R. J., and Soiffer, R. J., Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transpl, J Clin Oncol, vol. 30, no. 26, pp. 3194-201, 2012.
E. M. Denzen, Santibáñez, M. E. Burton, Moore, H., Foley, A., Gersten, I. D., Gurgol, C., Majhail, N. S., Spellecy, R., Horowitz, M. M., and Murphy, E. A., Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials., Biol Blood Marrow Transplant, vol. 18, no. 2, pp. 183-9, 2012.
J. Tolar, H Deeg, J., Arai, S., Horwitz, M., Antin, J. H., McCarty, J. M., Adams, R. H., Ewell, M., Leifer, E. S., Gersten, I. D., Carter, S. L., Horowitz, M. M., Nakamura, R., Pulsipher, M. A., DiFronzo, N. L., Confer, D. L., Eapen, M., and Anderlini, P., Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels., Biol Blood Marrow Transplant, vol. 18, no. 7, pp. 1007-11, 2012.
B. Foley, Cooley, S., Verneris, M. R., Curtsinger, J., Luo, X., Waller, E. K., Anasetti, C., Weisdorf, D., and Miller, J. S., Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen., J Immunol, vol. 189, no. 10, pp. 5082-8, 2012.
P. L. McCarthy, Owzar, K., Hofmeister, C. C., Hurd, D. D., Hassoun, H., Richardson, P. G., Giralt, S., Stadtmauer, E. A., Weisdorf, D. J., Vij, R., Moreb, J. S., Callander, N. Scott, van Besien, K., Gentile, T., Isola, L., Maziarz, R. T., Gabriel, D. A., Bashey, A., Landau, H., Martin, T., Qazilbash, M. H., Levitan, D., McClune, B., Schlossman, R., Hars, V., Postiglione, J., Jiang, C., Bennett, E., Barry, S., Bressler, L., Kelly, M., Seiler, M., Rosenbaum, C., Hari, P., Pasquini, M. C., Horowitz, M. M., Shea, T. C., Devine, S. M., Anderson, K. C., and Linker, C., Lenalidomide after stem-cell transplantation for multiple myeloma., N Engl J Med, vol. 366, no. 19, pp. 1770-81, 2012.
C. Anasetti, Logan, B. R., Lee, S. J., Waller, E. K., Weisdorf, D. J., Wingard, J. R., Cutler, C. S., Westervelt, P., Woolfrey, A., Couban, S., Ehninger, G., Johnston, L., Maziarz, R. T., Pulsipher, M. A., Porter, D. L., Mineishi, S., McCarty, J. M., Khan, S. P., Anderlini, P., Bensinger, W. I., Leitman, S. F., Rowley, S. D., Bredeson, C., Carter, S. L., Horowitz, M. M., and Confer, D. L., Peripheral-blood stem cells versus bone marrow from unrelated donors., N Engl J Med, vol. 367, no. 16, pp. 1487-96, 2012.
N. R. Kamani, Walters, M. C., Carter, S., Aquino, V., Brochstein, J. A., Chaudhury, S., Eapen, M., Freed, B. M., Grimley, M., Levine, J. E., Logan, B., Moore, T., Panepinto, J., Parikh, S., Pulsipher, M. A., Sande, J., Schultz, K. R., Spellman, S., and Shenoy, S., Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)., Biol Blood Marrow Transplant, vol. 18, no. 8, pp. 1265-72, 2012.